VFC and VFAAR Flu Vaccine Now Available to Order
- Fax in temperature logs since the last time your site ordered any vaccine up to the day you’re submitting the order
- Log onto KIDS Plus IIS at http://kids.phila.gov/
- Complete an initial reconciliation for flu (subsequent flu orders will only require a reconciliation completed within 60 days of your flu order)
- Check the “Will this be an influenza order?” box on the vaccine order page
- Order only what your site needs for a 4 to 6 week period
- Order only what you can store in your refrigerator
- Check the status of your order 2 business days later in KIDS Plus IIS to see if your order has been processed
- Check the VFC or VFAAR “Program Comments” section of your order screen to receive any notes regarding your order entry
PDPH will make every effort to fulfill your complete flu vaccine request; however, in the event that flu product is available in limited quantity, PDPH will reduce your order and notify you via the KIDS Plus IIS comment box.
Continue ordering flu vaccine throughout the season as needed. Keep vaccinating until product expires. Only use VFC vaccine to vaccinate VFC eligible patients (0-18 years and are uninsured, Medicaid, Native American/Alaska Native).
Flu vaccine may typically arrive separately from other vaccines even if flu and non-flu vaccines are ordered at the same time. The day you receive your flu order, log into KIDS Plus IIS and electronically receive the doses via the Pending VTrckS Shipment link from your On-Hand page. If you receive a vaccine shipment with an out-of-range temperature monitoring reading, please contact the Immunization Program immediately.
Paper Order Providers
Most providers order VFC and VFAAR vaccine through KIDS Plus IIS. If you still order with paper forms your process is a little different. Please read the following messages and follow the instructions. This is for authorized paper order providers only.
No VFC or VFAAR Vaccine Shipments During Papal Visit
The Philadelphia Department of Public Health will not be shipping vaccine orders county-wide from Wednesday, September 23 through Monday, September 28. Provider orders will not be processed, approved or shipped during these dates. This is in response to the Papal visit preparations in the City of Philadelphia.
All vaccine ordering functions and shipments will resume Tuesday, September 29. This applies to all vaccine processed by PDPH.
Providers are encouraged to review their inventory levels and project their vaccine need for the month of September.
To assist you in planning your vaccine need, please remember that vaccine is typically processed and shipped within 10 – 14 days of order submission. Flu orders are usually prioritized and get processed within 7 – 10 days (NOTE: As of today, there is no flu vaccine available for ordering. As soon as flu vaccine becomes available another health update will be released).
MenB Vaccines and VFC
New MenB Vaccines
The VFC Program now offers the two recently licensed meningococcal B vaccines, Bexsero®, manufactured by GlaxoSmithKline, and Trumenba®, manufactured by Pfizer Inc.
Meningococcal Group B Vaccines (MenB)
Both Bexsero® and Trumenba® are recombinant vaccines licensed in the United States for prevention of meningococcal serotype B disease in indicated persons 10 – 25 years of age. Meningococcal disease is a life-threatening illness caused by bacteria that can cause sepsis and meningitis. Thirteen different meningococcal serogroups have been defined, five of which cause the great majority of disease (A, B, C, Y, and W135). According to the CDC, approximately 500 total cases of meningococcal disease were reported in the U.S. in 2012, of which 160 (32%) were caused by serogroup B. The majority of the other cases of meningococcal disease were caused by the serogroups A, C, Y, and W135. Invasive disease with these 4 serogroups are preventable by meningococcal conjugate quadrivalent vaccines (MCV4; Menactra®, Sanofi Pasteur; Menveo®, GlaxoSmithKline), which have been supplied by VFC for many years.
The Philadelphia VFC Program will supply either of the two vaccines to VFC providers – at their choice – for VFC-eligible, medically-indicated patients 10 – 18 years of age, as detailed below.
Recommendations for Use of MenB Vaccines for VFC-Eligible Children
MenB should be administered to children 10 – 15 years of age at increased risk of meningococcal disease, due to one of the following:
- Children 10 – 15 years of age with persistent complement component deficiencies;
- Children 10 – 15 years of age with anatomic or functional asplenia;
- Children 10 – 15 years of age at risk because of a serogroup B meningococcal outbreak.
MenB may be administered to children 16 – 18 years of age who are determined to be at increased risk of meningococcal type B disease.
Administration of MenB Vaccines
Bexsero® vaccine is licensed as a two-dose schedule, given at least 28 days apart, i.e., at 0 and 1 month. Trumenba® vaccine is licensed as a three-dose schedule, given at 0, 1 – 2 months, and 6 months. Both Bexsero® and Trumenba® are supplied in 0.5 mL prefilled syringes, to be administered via intramuscular injection into the deltoid muscle of the upper arm. If vaccine is administered at intervals longer than recommended, there is no need to restart the series. Each MenB vaccine can be administered at the same visit as all other indicated vaccines.
Returning VFC/VFAAR Influenza Vaccine
Return All Unopened VFC/VFAAR Influenza Vaccine
All VFC and VFAAR 2014-15 seasonal flu vaccine expired June 30, 2015. These doses should be reported to the Philadelphia Immunization Program by July 31, 2015.
Reporting Flu Vaccine
If you order VFC/VFAAR vaccines online, you should now report the expiring flu vaccines online in KIDS Plus IIS. Register for vaccine returns training on this web form: http://goo.gl/forms/fkQIpsfr5r
If you order vaccines via paper logs, you should report these vaccines using the “Wasted” form for opened vials, and “Expired/Spoiled” form for unopened vials. Fax these forms to 215-238-6939. Discard the wasted vaccine, and set aside the expired/spoiled vaccine.
VFC Program: 9-valent HPV Vaccine
Philadelphia VFC Program
Beginning July 1, 2015, the Philadelphia Vaccines For Children (VFC) Program will cutover entirely to supplying the recently licensed recommended 9-valent human papillomavirus (9vHPV) GARDASIL®9 vaccine to replace the currently supplied 4-valent human papillomavirus (4vHPV) GARDASIL®4 vaccine. Both vaccines are manufactured by Merck, Sharpe and Dohme Corp.
Recommended 9vHPV Vaccine Immunization
The ACIP recommended 9vHPV for routine vaccination at 11-12 year for males and females. Catch-up vaccination is recommended for females 13-26 years and males up to 21 years and up to 26 years for MSM and immunocompromised males. The ACIP recommendation overrides the FDA approval.
Starting July 1, the Philadelphia VFC Program will no longer offer 4vHPV. That product will be replaced with 9vHPV. The 9vHPV vaccine follows the same recommended immunization schedule as 4vHPV.
For more information please read the March 27, 2015 ACIP recommendations published in the CDC’s MMWR.
Annual Program Re-enrollment
Vaccines for Children (VFC)
All VFC providers must complete the annual VFC Re-enrollment Forms. Please read and complete the re-enrollment forms by Friday, July 10, 2015.
Vaccines for Adults at Risk (VFAAR)
All VFAAR providers must complete the annual VFAAR Re-enrollment Forms. Please read and complete the re-enrollment forms by Friday, July 10, 2015.
KIDS Plus IIS
Please complete the KIDS Plus IIS Confidentiality Agreement and return it by Friday, July 10, 2015.